112 related articles for article (PubMed ID: 16396620)
1. Potent inhibitory activity of chimeric oligonucleotides targeting two different sites of human telomerase.
Matthes E; Lehmann C; Stulich M; Wu Y; Dimitrova L; Uhlmann E; Janta-Lipinski MV
Oligonucleotides; 2005 Dec; 15(4):255-68. PubMed ID: 16396620
[TBL] [Abstract][Full Text] [Related]
2. Telomerase protein rather than its RNA is the target of phosphorothioate-modified oligonucleotides.
Matthes E; Lehmann C
Nucleic Acids Res; 1999 Feb; 27(4):1152-8. PubMed ID: 9927750
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human telomerase by oligonucleotide chimeras, composed of an antisense moiety and a chemically modified homo-oligonucleotide.
Tarkanyi I; Horváth A; Szatmari I; Eizert H; Vámosi G; Damjanovich S; Ségal-Bendirdjian E; Aradi J
FEBS Lett; 2005 Feb; 579(6):1411-6. PubMed ID: 15733850
[TBL] [Abstract][Full Text] [Related]
4. Cellular delivery is a major obstacle for oligodeoxynucleotide inhibition of telomerase activity.
Duncan VE; Ajmani PS; Hughes JA
Anticancer Res; 1998; 18(6A):4105-8. PubMed ID: 9891453
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human telomerase activity by antisense phosphorothioate oligonucleotides encapsulated with the transfection reagent, FuGENE6, in HeLa cells.
Tamura Y; Tao M; Miyano-Kurosaki N; Takai K; Takaku H
Antisense Nucleic Acid Drug Dev; 2000 Apr; 10(2):87-96. PubMed ID: 10805159
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human telomerase activity by peptide nucleic acids.
Norton JC; Piatyszek MA; Wright WE; Shay JW; Corey DR
Nat Biotechnol; 1996 May; 14(5):615-9. PubMed ID: 9630953
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides.
Glukhov AI; Zimnik OV; Gordeev SA; Severin SE
Biochem Biophys Res Commun; 1998 Jul; 248(2):368-71. PubMed ID: 9675142
[TBL] [Abstract][Full Text] [Related]
8. Efficient telomerase inhibition in human non-small cell lung cancer cells by liposomal delivery of 2'-O-methyl-RNA.
Beisner J; Dong M; Taetz S; Piotrowska K; Kleideiter E; Friedel G; Schaefer U; Lehr CM; Klotz U; Mürdter TE
J Pharm Sci; 2009 May; 98(5):1765-74. PubMed ID: 18803262
[TBL] [Abstract][Full Text] [Related]
9. Specific inhibition of human telomerase activity by transfection reagent, FuGENE6-antisense phosphorothioate oligonucleotide complex in HeLa cells.
Tao M; Miyano-Kurosaki N; Takai K; Takaku H
FEBS Lett; 1999 Jul; 454(3):312-6. PubMed ID: 10431829
[TBL] [Abstract][Full Text] [Related]
10. Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells.
Kraemer K; Fuessel S; Schmidt U; Kotzsch M; Schwenzer B; Wirth MP; Meye A
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3794-800. PubMed ID: 14506173
[TBL] [Abstract][Full Text] [Related]
11. Efficient inhibition of human telomerase activity by antisense oligonucleotides sensitizes cancer cells to radiotherapy.
Ji XM; Xie CH; Fang MH; Zhou FX; Zhang WJ; Zhang MS; Zhou YF
Acta Pharmacol Sin; 2006 Sep; 27(9):1185-91. PubMed ID: 16923339
[TBL] [Abstract][Full Text] [Related]
12. [Inhibition of hTR activity for suppression of lung cancer cell proliferation using antisense phosphorothioate oligonucleotides].
Mei M; Yu H; Zhang W; Shi J; Yang J
Zhonghua Bing Li Xue Za Zhi; 2000 Jun; 29(3):204-7. PubMed ID: 11866914
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of telomerase by 2'-O-(2-methoxyethyl) RNA oligomers: effect of length, phosphorothioate substitution and time inside cells.
Elayadi AN; Demieville A; Wancewicz EV; Monia BP; Corey DR
Nucleic Acids Res; 2001 Apr; 29(8):1683-9. PubMed ID: 11292840
[TBL] [Abstract][Full Text] [Related]
14. Telomerase as a potential molecular target to study G-quartet phosphorothioates.
Sharma HW; Hsiao R; Narayanan R
Antisense Nucleic Acid Drug Dev; 1996; 6(1):3-7. PubMed ID: 8783790
[TBL] [Abstract][Full Text] [Related]
15. Protein and RNA of human telomerase as targets for modified oligonucleotides.
von Janta-Lipinski M; Gaertner K; Lehmann C; Scheer H; Schildt J; Matthes E
Nucleosides Nucleotides; 1999; 18(6-7):1719-20. PubMed ID: 10474255
[TBL] [Abstract][Full Text] [Related]
16. Efficient delivery of intact phosphodiester oligonucleotides by poly-beta-amino esters.
Remaut K; Symens N; Lucas B; Demeester J; De Smedt SC
J Control Release; 2010 May; 144(1):65-74. PubMed ID: 20114066
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human telomerase by 2'-O-methyl-RNA.
Pitts AE; Corey DR
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11549-54. PubMed ID: 9751703
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of telomere-mimic phosphorothioate oligodeoxy nucleotides (S-ODNS) on human tumor cell lines.
Saeki T; Takashima S; Tachibana M; Koga M; Hiyama E; Salomon DS; Holland JF; Ohnuma T
Oncology; 1999 Oct; 57 Suppl 2():27-36. PubMed ID: 10545800
[TBL] [Abstract][Full Text] [Related]
19. Plasmodium falciparum: effect of chemical structure on efficacy and specificity of antisense oligonucleotides against malaria in vitro.
Barker RH; Metelev V; Coakley A; Zamecnik P
Exp Parasitol; 1998 Jan; 88(1):51-9. PubMed ID: 9501848
[TBL] [Abstract][Full Text] [Related]
20. [Antisense oligonucleotides with antitumor activity].
Otvös L; Sági G
Magy Onkol; 2004; 48(3):221-7. PubMed ID: 15520872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
